Momenta Pharmaceuticals, Inc. (MNTA)

[rwwine]

my 2 cents.....i disagree with most of what is stated in the Credit Suisse comments as outlined here.

#1. I continue to believe that MNTA will get FDA approval without new clinical trial(s) for m-Copaxone.

#2. Given the experience MNTA had with m-Lovenox approval, I believe FDA approval will take place before the end of 2011.

#3. Finally, I see MNTA getting a positive outcome on the Copaxone litigation and moving m-Copaxone into the market before the end of 2011.